Langley, BC / Accesswire / June 2, 2021

Phyto Extractions Inc. Officially Launches Shatter For Adult-Use Market

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (Frankfurt: D2EP) (“Phyto Extractions™or the “Company”) strives to continuously bring consumers new and innovative products to enhance their experience and overall enjoyment. Shatter is Phyto Extractions™ latest new product category offering, with three new high THC extract, processed from single-source strains (local to BC and ON). Available in three strain types: Blue Gorilla OG, Pink Kush and D Bubba, each is extracted and processed in a controlled laboratory environment to prevent contaminants, and to ensure that all concentrate products are free of additives and synthetic fillers.
In partnership with Namaste Technologies Inc. subsidiary, CannMart Inc., Phyto Extractions™’ shatter is now available as of yesterday through licensed adult-use retailers in British Columbia, Saskatchewan and Manitoba. Strain availability will vary in each provincial distributor and private store. Pink Kush and D Bubba have been selected in British Columbia. All three SKUs; Blue Gorilla OG, D Bubba and Pink Kush will be available in Saskatchewan and Manitoba.
Blue Gorilla OG is a rare hybrid of the Glueberry OG and Blue Gorilla, creating a memorable, euphoric effect that will “stick like glue”. This flavour boasts over 70% of THC content and flavour notes of blueberry and pine wood. D. Bubba is the close sibling of the former, with 73.9% of THC and a distinctly dank smell imbued within, thanks to the hybrid plant-types of Death Star and Bubba Kush. Phyto Extractions™ shatter is also available in the classic Pink Kush variety, sure to entice users with a pleasantly sweet taste and robust THC content.
This is just the start of Phyto’s Shatter product line, with more exciting flavours already in development. Phyto Extractions™’ shatter products are extracted using the latest hydrocarbon extraction system, which outputs over 50KG of products a day. The Company has acquired the new extraction system and upgraded its production laboratory, with plans to expand its capacity and new product offerings for cannabis enthusiasts across Canada.
“Bringing high quality shelf stable shatter to the Canadian adult-use market, for a competitive price is a massive milestone for Phyto Extractions. Shatter is so fundamental to who we are as a company and we can’t wait to share it with consumers,” says Donald Dinsmore, COO, Phyto Extractions Inc.
To learn more about how Phyto Extractions™ shatter is made, please watch the following video:

About Phyto Extractions™

Phyto Extractions™ is an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction and products, no cultivation), Sales (extracts, topicals, and edibles), and R&D through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc.
ON BEHALF OF THE BOARD
PHYTO EXTRACTIONS INC. (CSE: XTRX)
Contact: Michael Forbes, President, CEO & Director (Chairman)
Phone: (778) 715-5011
Email: michael@phytoextractions.ca

About Namaste Technologies Inc.

CannMart Inc., a subsidiary of Namaste Technologies Inc. (TSXV: N, OTC: NXTTF), is a licensed entity, with a desktop and mobile portal that provides cannabis patients access to authorized and vetted medical cannabis products across Canada. CannMart medical patients are easily able to purchase Phyto Extractions products from the comfort of their home and have them delivered directly to their door once they have received their medical document.
Information on the Company and its many products can be accessed through the links below:
For more information please contact:
Namaste Technologies Inc. Meni Morim, CEO
Edward Miller, VP Investor Relations
Ph: 647-362-0390
Email: ir@namastetechnologies.com
Source: Namaste Technologies Inc

Forward-Looking Information:

This news release includes forward-looking information within the meaning of Canadian securities legislation, concerning the business of the Company. Forward-looking information is based on certain key expectations and assumptions made by the management of the Company. Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Forward-looking information in this news release includes statements with respect of the proposed name change, proposed consolidation, the closing of the private placement and the use of proceeds thereof. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward looking information, including: (i) adverse market conditions; (ii) risks inherent in the cannabis extraction sector in general; (iii) inability to close the private placement for any reason, or in the amounts expected by the Company; and (iv) other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements. The CSE has not reviewed or approved of any contents of this news release.